Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Apr 29

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Apr 29

DOI: 10.23736/S0026-4806.21.06970-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Influence of systemic manifestations of inflammatory bowel diseases on endothelial function and cardiovascular risk

Mariabeatrice PRINCIPI 1, Pietro SCICCHITANO 2, 3 , Sonia CARPARELLI 1, Rosa NITTI 3, Roberta RUGGIERI 3, Maria Consiglia BELLINO 3, Annagrazia CECERE 3, Fabio MANCA 4, Alfredo DI LEO 1, Marco M. CICCONE 3

1 Gastroenterology Unit, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy; 2 Cardiovascular Diseases Section, Hospital F. Perinei, Altamura, Bari, Italy; 3 Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy; 4 Department of Science of Educational, Psychology, and Communication, University of Bari, Bari, Italy


PDF


BACKGROUND: Inflammatory bowel diseases (IBD) may be complicated by extraintestinal manifestations (EIM). Both conditions may be implicated in the overall increase of cardiovascular (CV) risk profile of the patients. The study aimed to assess CV risk in IBD patients with EIMs in relation to the stages of both diseases.
METHODS: A total of 70 (38 men, mean age 51.7±12.4 years) patients with IBD and 22 controls (12 men, mean age 49.2±13.6 years) were enrolled. All patients and controls were screened for extraintestinal manifestations and underwent physical and anthropometric examinations, standard laboratory investigations, ultrasound evaluation of carotid arteries and flow-mediated vasodilatation (FMD). Patients were divided into four groups in relation to their active or remission stage of
disease: 1. IBD+ EIM+; 2. IBD+ EIM-; 3. IBD- EIM+; 4. IBD- EIM-.
RESULTS: The groups were homogenous according to their clinical characteristics. Patients with both IBD and EIM in active phase showed significantly lower values in FMD than controls (p=0.024). Carotid intima-media thickness values (cIMT) were similar among groups. Patients with active phases of IBD and/or EIM showed statistically significant lower values in FMD measurements (p=0.0008 and p=0.0011, respectively). Multivariate regression did not reveal any independent predictors for FMD values.
CONCLUSIONS: The active phase of IBD or EIM or both may promote endothelial dysfunction in patients, thus increasing their CV risk profile. Patients in remission phase showed endothelial function similar at controls.


KEY WORDS: Endothelial function; Flow-mediated vasodilatation; Inflammatory bowel diseases; Common carotid artery intima-media thickness; Extraintestinal manifestations

top of page